Literature DB >> 16943404

The value of medical spending in the United States, 1960-2000.

David M Cutler1, Allison B Rosen, Sandeep Vijan.   

Abstract

BACKGROUND: The increased use of medical therapies has led to increased medical costs. To provide insight into the value of this increased spending, we compared gains in life expectancy with the increased costs of care from 1960 through 2000.
METHODS: We estimated life expectancy in 1960, 1970, 1980, 1990, and 2000 for four age groups. To control for the influence of nonmedical factors on survival, we assumed in our base-case analysis that 50 percent of the gains were due to medical care. We compared the adjusted increases in life expectancy with the lifetime cost of medical care in the same years.
RESULTS: From 1960 through 2000, the life expectancy for newborns increased by 6.97 years, lifetime medical spending adjusted for inflation increased by approximately 69,000 dollars, and the cost per year of life gained was 19,900 dollars. The cost increased from 7,400 dollars per year of life gained in the 1970s to 36,300 dollars in the 1990s. The average cost per year of life gained in 1960-2000 was approximately 31,600 dollars at 15 years of age, 53,700 dollars at 45 years of age, and 84,700 dollars at 65 years of age. At 65 years of age, costs rose more rapidly than did life expectancy: the cost per year of life gained was 121,000 dollars between 1980 and 1990 and 145,000 dollars between 1990 and 2000.
CONCLUSIONS: On average, the increases in medical spending since 1960 have provided reasonable value. However, the spending increases in medical care for the elderly since 1980 are associated with a high cost per year of life gained. The national focus on the rise in medical spending should be balanced by attention to the health benefits of this increased spending. Copyright 2006 Massachusetts Medical Society.

Mesh:

Year:  2006        PMID: 16943404     DOI: 10.1056/NEJMsa054744

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  105 in total

1.  Bias in high-tier medical journals concerning physician-academic relationships with industry.

Authors:  Roman Lesko; Samuel Scott; Thomas P Stossel
Journal:  Nat Biotechnol       Date:  2012-04-10       Impact factor: 54.908

2.  Spending more money, saving more lives? The relationship between avoidable mortality and healthcare spending in 14 countries.

Authors:  Richard Heijink; Xander Koolman; Gert P Westert
Journal:  Eur J Health Econ       Date:  2012-06-08

3.  The cost of an additional disability-free life year for older Americans: 1992-2005.

Authors:  Liming Cai
Journal:  Health Serv Res       Date:  2012-06-07       Impact factor: 3.402

4.  How healthy could a state be?

Authors:  David Kindig; Paul Peppard; Bridget Booske
Journal:  Public Health Rep       Date:  2010 Mar-Apr       Impact factor: 2.792

5.  US trends in quality-adjusted life expectancy from 1987 to 2008: combining national surveys to more broadly track the health of the nation.

Authors:  Susan T Stewart; David M Cutler; Allison B Rosen
Journal:  Am J Public Health       Date:  2013-09-12       Impact factor: 9.308

Review 6.  Advancing cardiovascular research.

Authors:  Michael S Lauer
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

7.  Economic evidence at the local level : options for making it more useful.

Authors:  Kees van Gool; Gisselle Gallego; Marion Haas; Rosalie Viney; Jane Hall; Robyn Ward
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

8.  Evaluating the impact of prioritization of antiretroviral pre-exposure prophylaxis in New York.

Authors:  Jason Kessler; Julie E Myers; Kimberly A Nucifora; Nana Mensah; Christopher Toohey; Amin Khademi; Blayne Cutler; Scott Braithwaite
Journal:  AIDS       Date:  2014-11-28       Impact factor: 4.177

9.  Healthcare costs and obesity prevention: drug costs and other sector-specific consequences.

Authors:  David R Rappange; Werner B F Brouwer; Rudolf T Hoogenveen; Pieter H M Van Baal
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

10.  Is survival better at hospitals with higher "end-of-life" treatment intensity?

Authors:  Amber E Barnato; Chung-Chou H Chang; Max H Farrell; Judith R Lave; Mark S Roberts; Derek C Angus
Journal:  Med Care       Date:  2010-02       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.